# Tecfidera and the Gut Microbiota

> **NCT02471560** · PHASE4 · COMPLETED · sponsor: **Biogen** · enrollment: 36 (actual)

## Conditions studied

- Multiple Sclerosis, Relapsing-Remitting

## Interventions

- **DRUG:** dimethyl fumarate
- **DRUG:** injectable MS DMT

## Key facts

- **NCT ID:** NCT02471560
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-06
- **Primary completion:** 2017-06-12
- **Final completion:** 2017-06-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02471560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02471560, "Tecfidera and the Gut Microbiota". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02471560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*